The expansion is a good signal for an industry that slowed down, both in Chicago and nationwide, as interest rates rose and ...

Researchers in the field of exposomics explain how cutting-edge technologies are unlocking this biological archive, ushering in a new era of disease prevention and personalized medicine.

Indiana University School of Medicine scientists have developed a powerful new imaging technique to study bone marrow in ...

Pittsburgh biotech firms see potential benefits from upcoming tariffs and reshoring efforts, despite uncertainties in NIH ...

Rezolute advances HI drug trial after DMC review and secures $90 million in funding through stock offering to support ...

Ex-Google CEO Eric Schmidt warns AI could surpass human control by 2026. Discover the risks and opportunities of artificial ...

ORIC Pharmaceuticals is advancing ORIC-114 for 1st-line EGFR/HER2 exon 20 NSCLC, with comprehensive data expected in the 2nd ...

Biomedical Research leads at USD 1.5 billion, supporting genetic discovery and translational research.

On the buying side, ARK’s ARKG ETF acquired 2161 shares of biopharmaceutical giant Amgen Inc (NASDAQ: AMGN ), with a total investment of around $599,223. This purchase signals a growing interest in ...

The NIH director asserted the agency remains committed to research that advances the health of minorities, despite Trump's ...

New Phase II data demonstrate amlitelimab’s efficacy in heterogeneous inflammatory asthma, as lunsekimig and itepekimab ...

This article examines the legal implications of AI in healthcare, focusing on liability issues and the need for clear ...